BRCCH Consortium Member
Yves Blickenstorfer is a fourth-year PhD student at ETH Zurich in the field of biosensing. Prior to his PhD, he studied material science at ETH Zurich. During the past four years, he has worked on developing and optimizing the hardware and software for different novel biosensing technologies and modelling their quantitative response. He is currently focusing on sensitive electrochemical detection of gold nanoparticles in order to improve rapid diagnostic testing. He was involved in the founding of the Roche spin-off Lino Biotech and will be the CTO of Hemetron, a newly founded start-up at ETH Zurich.